Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide

8 Oct 2012

Abstract excerpt

// Joanna Triscott 1 , Cathy Lee 1 , Kaiji Hu 1 , Abbas Fotovati 1 , Rachel Berns 1 , Mary Pambid 1 , Margaret Luk 2 , Richard E. Kast 3 , Esther Kong 4 , Eric Toyota 4 , Stephen Yip 4 , Brian Toyota 5 and Sandra E. Dunn 1 1 Department of Pediatrics, University of British Columbia, Vancouver, BC 2 Department of Pathology, Vancouver General Hospital, Vancouver, BC 3 Department of Psychiatry, University of Vermont,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer, Hypoxia, and Metabolism
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23047041
DOI: 10.18632/oncotarget.604

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomidePMID 23047041Read ↗

Concise Review: Bullseye: Targeting Cancer Stem Cells to Improve the Treatment of Gliomas by Repurposing DisulfiramSemantic proximity Read ↗

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoSemantic proximity Read ↗

Non-oncology drugs are a source of previously unappreciated anti-cancer activitySemantic proximity Read ↗

Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating CellsSemantic proximity Read ↗

Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtypeSemantic proximity Read ↗

Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cellsSemantic proximity Read ↗

Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents.Semantic proximity Read ↗

A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem CellsSemantic proximity Read ↗

A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancerSemantic proximity Read ↗

Metabolic remodeling by the PD-L1 inhibitor BMS-202 significantly inhibits cell malignancy in human glioblastomaSemantic proximity Read ↗

PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38MAPK signallingSemantic proximity Read ↗

Combined Treatment with Dopamine Receptor Antagonists and Radiation Creates a Metabolic Vulnerability in Mouse Models of GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.